Jazz Pharmaceuticals director proposes $3.36M sale

Morgan Stanley Smith Barney LLC is listed as broker, and the proposed-sale shares are identified as acquired through a stock option exercise.

Rhea-AI Filing Summary

Jazz Pharmaceuticals plc (JAZZ) is named as issuer in a Rule 144 notice for director Anne O’Riordan’s proposed sale of 14,687 common shares on October 8, 2026, with an aggregate market value of $3,356,713.85. Morgan Stanley Smith Barney LLC is listed as broker, and the shares are identified as acquired through a stock option exercise. The notice also lists O’Riordan’s sale of 1,692 common shares on August 7, 2026, for $435,673.08.

Key Figures

Proposed shares for sale: 14,687 common shares Proposed-sale aggregate market value: $3,356,713.85 Issuer shares outstanding: 64,914,577 shares +2 more

5 metrics

Proposed shares for sale 14,687 common shares Proposed sale on October 8, 2026

Proposed-sale aggregate market value $3,356,713.85 Proposed sale

Issuer shares outstanding 64,914,577 shares Reported in the securities information

Shares sold during the past three months 1,692 common shares Sale on August 7, 2026

Aggregate market value of prior sale $435,673.08 Sale on August 7, 2026

Key Terms

Rule 144, Stock Option Exercise, Securities Sold During The Past 3 Months

3 terms

Rule 144 regulatory

"Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

Securities Sold During The Past 3 Months regulatory

"Securities Sold During The Past 3 Months"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many JAZZ shares does director Anne O’Riordan propose to sell?

Anne O’Riordan proposes to sell 14,687 common shares on October 8, 2026, with an aggregate market value of $3,356,713.85.

How were Anne O’Riordan’s proposed JAZZ shares acquired?

The proposed-sale shares are identified as acquired through a stock option exercise from the issuer.

What JAZZ shares did Anne O’Riordan sell in the previous three months?

The notice lists a sale of 1,692 common shares on August 7, 2026, for an aggregate market value of $435,673.08.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/08/2026 - 04:04 PM Accepted by SEC EDGAR 10/08/2026 - 04:04 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001767870
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	JAZZ PHARMACEUTICALS PUBLIC LIMITED COMPANY
SEC File Number	001-33500
Address of Issuer	Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 IRELAND D04 E5W7
Phone	011-353-1-634-7800
Name of Person for Whose Account the Securities are To Be Sold	ANNE O'RIORDAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	14687	3356713.85	64914577	10/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/08/2026	Stock Option Exercise	Issuer			14687	10/08/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANNE O'RIORDAN Fifth Floor, Waterloo Exchange Waterloo Road Dublin 4 L2 D04 E5W7	Common	08/07/2026	1692	435673.08

144: Remarks and Signature

Remarks
Date of Notice	10/08/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Anne Oriordan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)